Skip to content

IQVIA IQV Price / earnings

Price / earnings at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
26.7×-2.2×
UnitedHealth Group logo
UnitedHealth GroupUNH
20.4×-1.3×
Labcorp Holdings logo
Labcorp HoldingsLH
23.4×-3.3×
Cognizant logo
CognizantCTSH
13.2×-2.9×
Oracle logo
OracleORCL
25.8×-12.4×
Veeva Systems logo
Veeva SystemsVEEV
27.1×-20.4×

Other financials

Income statement

See full
Revenue$4.2B+8.4%
Gross profit$1.4B+4.4%
Operating income$514.0M+3.6%
Net income$274.0M+10.0%
EPS (diluted)$1.61+15.0%

Balance sheet

See full
Cash & equivalents$1.9B+11.9%
Total debt$16.1B+10.7%
Total equity$6.2B+4.1%
Total assets$29.7B+8.6%

Cash flow

See full
Operating cash flow$618.0M+8.8%
CapEx$127.0M-10.6%
Free cash flow$491.0M+15.3%

Valuation

See full
Market cap$28B-7.9%
Enterprise value$42.12B-2.5%
P/S1.7×-0.3×

Profitability

See full
Gross margin33%-1.7pp
Operating margin13.2%-0.9pp
Net margin8.3%-0.3pp
FCF margin12.7%-1.2pp

Returns & leverage

See full
Return on equity22.7%+1.1pp
Debt / equity2.6×+0.2×
Current ratio0.7×-0.1×

Where this comes from

Calculated from IQVIA’s reported figures.

Based on the most recent quarter.

The official record: IQVIA’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about IQVIA's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is IQVIA's price / earnings?
IQVIA (IQV) reported price / earnings of 20.7× in Q1 2026.
How has IQVIA's price / earnings changed year-over-year?
IQVIA's price / earnings decreased by 11.3% year-over-year, from 23.3× to 20.7×.
What is the long-term trend for IQVIA's price / earnings?
Over 5 years (2020 to 2025), IQVIA's price / earnings has grown at a -25.5% compound annual growth rate (CAGR), from 123× to 28.2×.
What does price / earnings mean?
How many dollars investors pay for each dollar of the company's annual profit.
How do you interpret price / earnings?
Lower can mean cheaper — or that the market expects earnings to fall. High multiples embed growth expectations. Meaningless when earnings are negative, so it is suppressed there.
How does price / earnings compare across companies?
Compare against the company's own history and sector peers, not across sectors with different growth and risk profiles.